Beibei Yang

Title: Beibei Yang: Innovator in Pharmaceutical Chemistry

Introduction

Beibei Yang is a prominent inventor based in Lianyungang, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug derivatives. Her work focuses on enhancing the efficacy of treatments for diseases mediated by anaplastic lymphoma kinase.

Latest Patents

Beibei Yang holds 1 patent for her invention titled "Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof." This invention relates to a deuterium-modified Brigatinib derivative, which exhibits excellent inhibitory activity on anaplastic lymphoma kinase. The preparation method, pharmaceutical composition, and uses of this derivative are aimed at creating effective medicaments for treating related diseases. The deuterium-modified Brigatinib derivative demonstrates improved pharmacodynamic and pharmacokinetic properties compared to the original Brigatinib.

Career Highlights

Beibei Yang is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the pharmaceutical industry, contributing to the creation of innovative therapies.

Collaborations

Beibei Yang collaborates with esteemed colleagues, including Yinsheng Zhang and Baomin Liu. These partnerships enhance her research capabilities and foster innovation within her field.

Conclusion

Beibei Yang's contributions to pharmaceutical chemistry, particularly through her patented inventions, highlight her role as an influential inventor. Her work not only advances medical science but also offers hope for improved treatments for patients.